The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury.
about
Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders.cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases.Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.
P2860
The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The new iminothiadiazole deriv ...... e after an excitotoxic injury.
@en
The new iminothiadiazole deriv ...... e after an excitotoxic injury.
@nl
type
label
The new iminothiadiazole deriv ...... e after an excitotoxic injury.
@en
The new iminothiadiazole deriv ...... e after an excitotoxic injury.
@nl
prefLabel
The new iminothiadiazole deriv ...... e after an excitotoxic injury.
@en
The new iminothiadiazole deriv ...... e after an excitotoxic injury.
@nl
P2093
P2860
P1476
The new iminothiadiazole deriv ...... e after an excitotoxic injury.
@en
P2093
Ana Perez-Castillo
Angel Santos
Carmen Gil
Cristina Susín
Diana Aguilar-Morante
Jose A Morales-Garcia
Marina Sanz-Sancristobal
Sandra Alonso-Gil
Valle Palomo
P2860
P304
P356
10.1111/J.1471-4159.2012.07866.X
P407
P50
P577
2012-08-03T00:00:00Z